Circulating amphiregulin (AR) plasma levels as surrogate pharmacodynamic markers of EGFR inhibition with cetuximab in metastatic colorectal cancer (MCRC) patients
Abstract
Publication Date:
2010
Citation:
Circulating amphiregulin (AR) plasma levels as surrogate pharmacodynamic markers of EGFR inhibition with cetuximab in metastatic colorectal cancer (MCRC) patients / L. F., C. Cremolini, F. A., L. C., F. I., O. P., S. E., C. B., S. L., D.D. T., M. G., G. Fontanini, R. Danesi, G. Bocci, A. Falcone - In: Proceedings 12th World Congress on Gastrointestinal Cancer (ESMO Conference)[s.l], 2010. - pp. vi36 (( convegno 12th World Congress on Gastrointestinal Cancer (ESMO Conference). tenutosi a Barcelona, Spain nel 30 June - 3 July.
IRIS type:
03 - Contributo in volume
List of contributors:
L. F., C. Cremolini, F. A., L. C., F. I., O. P., S. E., C. B., S. L., D.D. T., M. G., G. Fontanini, R. Danesi, G. Bocci, A. Falcone
Link to information sheet:
Book title:
Proceedings 12th World Congress on Gastrointestinal Cancer (ESMO Conference)